معرفی
Dr. Michael Burgum is a Research Fellow in Biomedical Sciences at Swansea University's Faculty of Medicine, Health and Life Science. He holds a PhD in Genetic Toxicology (2019) and is a senior member of the In Vitro Toxicology Group. His role as a Research Officer involves leading projects like Horizon 2020 RiskGONE and NanoInformaTIX, focusing on nanomaterial risk assessment and protocol development for regulatory toxicology. He is a basic Welsh speaker and available for postgraduate supervision.
Education: PhD in Genetic Toxicology (Swansea University, 2019). His thesis investigated inhalation hazards of graphene nanomaterials in advanced in vitro lung models.
Research Interests: Regulatory toxicology, nanomaterial mutagenicity, and characterization. Specializes in in vitro models for assessing genotoxicity, with expertise in electron microscopy and genetic toxicity assays. His work emphasizes harmonizing evaluation protocols for nanomaterials and improving OECD test guidelines.
Teaching: Leads modules on Nanotoxicology (PM-351) and Nano(geno)toxicology (PM-M28), covering nanotechnology risks and practical toxicology methodologies.
Grants/Projects: Involved in multi-partner Horizon 2020 initiatives, advancing standardized data-reporting frameworks for nanomaterials and indoor air pollution studies. His research bridges laboratory models with real-world risk management strategies.
Labs/Teams: Core member of the In Vitro Toxicology Group, collaborating across European institutions to develop robust nano-specific toxicology protocols.
